1 |
Thomas, K. J., J. P. Nicholl and P. Coleman. 2001. Use and expenditure on complementary medicine in England: a population based survey. Complement Ther. Med. 9, 2-11
DOI
ScienceOn
|
2 |
Ward, B. A., J. C. Gorski, D. R. Jones, S. D. Hall, D. A Flockhart and Z. Desta. 2003. The cytochrome P450 2B6 (CYP2B6) is the main catalyst of efavirenz primary and secondary metabolism: implication for HIV/AIDS therapy and utility of efavirenz as a substrate marker of CYP2B6 catalytic activity. J. Pharmacol. Exp. Ther. 306, 287-300
DOI
ScienceOn
|
3 |
Zhou, S., Y. Gao, W. Jiang, M. Huang, A. Xu and J. W. Paxton. 2003. Interactions of herbs with cytochrome P450. Drug Metab. Rev. 35, 35-98
DOI
ScienceOn
|
4 |
Hesse, L. M., K. Venkatakrishnan, M. H. Court, L. L. von Moltke, S. X. Duan, R. I. Shader and D. J. Greenblatt. 2000. CYP2B6 mediates the in vitro hydroxylation of bupropion: potential drug interactions with other antidepressants. Drug Metab. Dispos. 28, 1176-1183
|
5 |
Ioannides, C. 2002. Pharmacokinetic interactions between herbal remedies and medicinal drugs. Xenobiotica 32, 451-478
DOI
ScienceOn
|
6 |
Izzo, A. A. 2004. Drug interactions with St. John's Wort (Hypericum perforatum): a review of the clinical evidence. Int. J. Clin. Pharmacol. Ther. 42, 139-148
DOI
|
7 |
Kim, M. J., H. Kim, I. J. Cha, J. S. Park, J. H. Shon, K. H. Liu and J. G. Shin. 2005. High-throughput screening of inhibitory potential of nine cytochrome P450 enzymes in vitro using liquid chromatography/tandem mass spectrometry. Rapid Commun. Mass Spectrom. 19, 2651-2658
DOI
ScienceOn
|
8 |
Lee, M. S., H. J. Lim, M. S. Lee and H. S. Jang. 2005. Perceptions, knowledge and misuse of an oriental herbal drug: a survey of 608 Korean female nursing college students. Complement Ther. Clin. Pract. 11, 200-204
DOI
ScienceOn
|
9 |
Lu, T., Y. Liang, J. Song, L. Xie, G. J. Wang and X. D. Liu. 2006. Simultaneous determination of berberine and palmatine in rat plasma by HPLC-ESI-MS after oral administration of traditional Chinese medicinal preparation Huang-Lian-Jie-Du decoction and the pharmacokinetic application of the method. J. Pharm. Biomed. Anal. 40, 1218-1224
DOI
ScienceOn
|
10 |
Markowitz, J. S., C. L. DeVane, D. W. Boulton, S. W. Carson, Z. Nahas and S. C. Risch. 2000. Effect of St. John's wort (Hypericum perforatum) on cytochrome P-450 2D6 and 3A4 activity in healthy volunteers. Life Sci. 66, PL133-139
DOI
ScienceOn
|
11 |
Guengelich, F. P. 1996. In vitro techniques for studying drug metabolism. J. Pharmacokinet. Biopharm. 24, 521-533
DOI
ScienceOn
|
12 |
Nakajima, M., K. Kobayashi, K. Oshima, N. Shimada, S. Tokudome, K. Chiba and T. Yokoi. 1999. Activation of phenacetin O-deethylase activity by alpha-naphthoflavone in human liver microsomes. Xenobiotica 29, 885-898
DOI
ScienceOn
|
13 |
Chatterjee, P. and M. R. Franklin. 2003. Human cytochrome p450 inhibition and metabolic-intermediate complex formation by goldenseal extract and its methylenedioxyphenyl components. Drug Metab. Dispos. 31, 1391-1397
DOI
ScienceOn
|
14 |
De Smet, P. A. 2002. Herbal remedies. N. Engl. J. Med. 347, 2046-2056
DOI
ScienceOn
|
15 |
Hwang, Y. S., C. Y. Shin, Y. Huh and J. H. Ryu. 2002. Hwangryun-Hae-Dok-tang (Huanglian-Jie-Du-Tang) extract and its constituents reduce ischemia-reperfusion brain injury and neutrophil infiltration in rats. Life Sci. 71, 2105-2017
DOI
ScienceOn
|
16 |
Guengerich, F. P. 1997. Role of cytochrome P450 enzymes in drug-drug interactions. Adv. Pharmacol. 43, 7-35
DOI
|
17 |
Henderson, L., Q. Y. Yue, C. Bergquist, B. Gerden, and P. Arlett. 2002. St John's wort (Hypericum perforatum): drug interactions and clinical outcomes. Br. J. Clin. Pharmacol. 54, 349-356
DOI
ScienceOn
|
18 |
Guerra, M. C., E. Speroni, M. Broccoli, M. Cangini, P. Pasini, A. Minghett, N. Crespi-Perellino, M. Mirasoli, G. Cantelli-Forti and M. Paolini 2000. Comparison between chinese medical herb Pueraria lobata crude extract and its main isoflavone puerarin antioxidant properties and effects on rat liver CYP-catalysed drug metabolism. Life Sci. 67, 2997-3006
DOI
ScienceOn
|